Delivery Order SPE2DB22D9239-SPE2DB25FDL02
- Not listed
- The Defense Logistics Agency awarded a $29,168 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of VABYSMO 6 mg/0.05 ml vials. The award, issued on September 9, 2025, with an ultimate completion date of September 30, 2025, carries no set-aside designation. DMS Pharmaceutical Group will perform the work at its Park Ridge facility and deliver the pharmaceutical product to support...
- The Defense Logistics Agency (DLA), functioning as part of the Department of Defense's Medical Supply Chain, awarded a delivery order valued at $8,655.50 to DMS Pharmaceutical Group Inc. for the supply of VABYSMO 6MG/0.05ML. This firm fixed-price delivery order, issued on June 25, 2025, with an ultimate completion date of the same day, represents a discrete pharmaceutical product delivery under DMS Pharmaceutical Group's larger indefinite delivery contract with the DLA. The award was made...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $29.8K on July 21, 2025, for the supply of Vabysmo 6 mg/0.05 mL syringes. This firm fixed-price delivery order is set to be completed by August 11, 2025, and represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program. The parent contract,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $11,933.76 on July 18, 2025, for the supply of Vabysmo 6 mg/0.05 mL syringes. The award carries an ultimate completion date of August 8, 2025, and represents a specific delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at approximately $500...
- The Defense Logistics Agency awarded a delivery order valued at $4,475.16 to DMS Pharmaceutical Group Inc. on August 12, 2025, for the supply of VABYSMO 6 mg/0.05 ml syringes. VABYSMO is a prescription pharmaceutical product used in ophthalmology for treating retinal conditions. The delivery order is firm fixed price with no set-aside designation and is scheduled for ultimate completion by September 3, 2025, with performance taking place in Park Ridge, Illinois. This delivery order is issued...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $14,917.20 by the Defense Logistics Agency (DLA) on September 15, 2025. The delivery order, which has an ultimate completion date of October 6, 2025, covers the supply of Vabysmo 6 mg/0.05 mL syringes for delivery to Park Ridge, Illinois. This award was issued without a set-aside designation, allowing the contractor to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,966.88 to DMS Pharmaceutical Group Inc. for VABYSMO 6 mg/0.05 ml syringes on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a direct procurement of pharmaceutical supplies to support military healthcare operations. VABYSMO is a prescription ophthalmic medication used in treating age-related macular degeneration, and...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,966.88 by the Defense Logistics Agency (DLA) on September 5, 2025. The contract calls for the delivery of Vabysmo 6 mg/0.05 ml syringes, a prescription medication used in ophthalmic treatment. The order has an ultimate completion date of September 26, 2025, and carries no set-aside designation. This delivery order falls...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency on September 18, 2025, for the supply of Vabysmo 6 mg/0.05 mL vials. The contract, valued at $2,916.80 with a firm fixed-price structure, is scheduled for completion by October 9, 2025, and carries no set-aside designation. This delivery order represents a continuation of DMS Pharmaceutical Group's substantial engagement...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $5,966.88 by the Defense Logistics Agency on August 6, 2025, for the supply of Vabysmo 6 mg/0.05 ml syringes. This firm fixed-price delivery order, with an ultimate completion date of August 27, 2025, represents a discrete purchase under the company's larger Indefinite Delivery Contract with the DLA. The award carries no set-aside...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB25FDL02Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $14,584.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Vabysmo 6 mg/0.05 ml vials. This firm fixed-price delivery order, issued on August 8, 2025, with an ultimate completion date of August 29, 2025, does not utilize any set-aside designation. The award represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499,999,999 and valid through November 2026 under the SPE2DB program, which enables the agency to procure a comprehensive range of pharmaceutical products to support military health facilities worldwide. Vabysmo is a prescription pharmaceutical product used in ophthalmology for treating age-related macular degeneration and diabetic macular edema. DMS Pharmaceutical Group maintains a robust portfolio of federal pharmaceutical supply contracts with the Defense Logistics Agency, distributing branded and generic prescription drugs, biologics, and medical consumables across diverse therapeutic categories to military healthcare systems. The company's consistent success in securing delivery orders reflects its established position as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in federal procurement markets while maintaining direct distribution capabilities to Department of Defense healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.6k | 8/8/25 |